Expression of Osteopontin in Patients with Thyroid Dysfunction

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Reza, Sara ^a   Shaukat, Asma ^a   Arain, Tariq M ^b   Riaz, Qasim Sarwar ^c   Mahmud, Maria ^d  

^a QUAID E AZAM MEDICAL COLLEGE   (Pakistan)

^b BAHAWAL VICTORIA HOSPITAL   (Pakistan)

^c St John Providence Health System   (United States)

^d CARLETON UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN; THYROTROPIN;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DOWN REGULATION; FEMALE; GOITER; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; THYROID DISEASE; THYROTROPIN BLOOD LEVEL;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; FEMALE; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; MIDDLE AGED; OSTEOPONTIN; PROGNOSIS; THYROTROPIN; THYROXINE;

EID: 84874259013     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056533     Document Type: Article

References (54)

1. Khan A, Khan MMA, Akhtar S, (2002) Thyroid disorders, etiology and prevalence. J Med Sci 2: 89-94.
2. Mansoor R, Rizvi SR, Huda ST, Khan C, (2010) Spectrum of thyroid diseases: An experience in the tertiary care and teaching hospital. Ann Pak Inst Med Sci 6: 101-106.
3. Andersen S, Andersan KM, Bruun NH, Laurberg P, (2002) Narrow individual variations in serum T4 and T3 in normal subjects: A clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 87: 1068-1072.
4. Shamon M (2009) New guidelines say million More at Thyroid Risk about.com. Health's' Disease and Condition. Available: http://thyroid.about.com/cs/testsforthyroid/a/newrange.htm. Accessed 16 December 2011.
5. Phillips JA (2001) Thyroid Hormone Disorders. Available: http://csa.com/discoveryguides/thyroid/overview.php. Accessed 24 December 2011.
6. Saha PK, Baur B, Gupta S, (2007) Thyroid stimulating hormone measurement as the confirmatory diagnosis of hypothyroidism: A study from a tertiary-care teaching hospital, Kolkatta. Ind J Com Med 32: 139-140.
7. Arora S, Chavla R, Tayal D, Gupta VK, Sohi JS, et al. (2009) Biochemical markers of liver & kidney function are influenced by thyroid function-a case controlled follow up study in Indian hypothyroid subjects. Ind J Clin Biochem 24: 370-374.
8. Boeelaert K, Franklyn JA, (2005) Thyroid hormone in health and disease. J Endocrinol 187: 1-15.
9. Yen PM, (2001) Physiology and molecular basis of thyroid hormone action. Physiol Rev 81: 1097-1142.
10. Riaz M, Salman A, Fawwad A, (2009) Trends of serum thyrotropin concentration and associated factors in urban Pakistan (Karachi). Int J Endocrinol Metab 1: 12-19.
11. Heinegard D, Hultenby K, Oldberg A, Reinholt F, Wendel M, (1989) Macromolecules in bone matrix. Connect Tissue Res 21: 3-11.
12. Nau GJ (2000) Osteopontin. In: Oppenhium JJ, Feldmann M, Durum SK, editors. Cytokine reference: A compendium of cytokines and other mediators of host defense. 1st ed. San Diego: Academic press. 689-701.
13. Laffón A, García-Vicuña R, Humbría A, Postigo AA, Corbí AL, et al. (1991) Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis. J Clin Invest 88: 546-552.
14. Seiffge D, (1996) Protective effects of monoclonal antibody to VLA-4 on leukocyte adhesion and course of disease in adjuvant arthritis in rats. J Rheumatol 23: 2086-2091.
15. Zohar R, Suzuki N, Suzuki K, Arora P, Glogauer M, et al. (2000) Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. J Cell Physiol 184: 118-130.
16. Suzuki K, Zhu B, Rittling SR, Denhardt DT, Goldberg HA, et al. (2002) Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts. J Bone Miner Res 17: 1486-1497.
17. Zhu B, Suzuki K, Goldberg HA, Rittling SR, Denhardt DT, et al. (2004) Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin. J Cell Physiol 198: 155-167.
18. Junaid A, Moon MC, Harding GE, Zahradka P, (2007) Osteopontin localizes to the nucleus of 293 cells and associates with polo-like kinase-1. Am J Physiol Cell Physiol 292: 919-926.
19. He B, Mirza M, Weber GF, (2006) An osteopontin splice variant induces anchorage independence in human breast cancer cells. Oncogene 25: 2192-2202.
20. Mirza M, Shaughnessy E, Hurley JK, Vanpatten KA, Pestano GA, et al. (2008) Osteopontin-c is a selective marker of breast cancer. Int J Cancer 122: 889-897.
21. Ashizawa N, Graf K, Do YS, Nunohiro T, Giachelli CM, et al. (1996) Osteopontin is produced by rat cardiac fibroblasts and mediates A (II)-induced DNA synthesis and collagen gel contraction. J Clin Invest 98: 2218-2227.
22. Murry CE, Giachelli CM, Schwartz SM, (1994) Vracko (1994) Macrophages express osteopontin during repair of myocardial necrosis. Am J Patho 145: 1450-1462.
23. Uaesoontrachoon K, Yoo HJ, Tudor E, Pike RN, Mackie EJ, et al. (2008) Osteopontin and skeletal muscle myoblasts: Association with muscle regeneration and regulation of myoblast function in vitro. Int J Biochem Cell Biol 40: 2303-2314.
24. Gursoy G, Acar Y, Alagoz S, (2010) Osteopontin: A multifunctional molecule. J Med Sci 1: 55-60.
25. Nau GJ (2000) Osteopontin receptor. In: Oppenhium JJ, Feldmann M, Durum SK, editors. Cytokine reference: A compendium of cytokines and other mediators of host defense. 1st ed. San Diego: Academic press. 1859-1870.
26. Guo H, Cai CQ, Schroeder RA, Kuo PC, (2001) Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages. J Immunol 166: 1079-1086.
27. Ricardo SD, Franzoni DF, Roesener CD, Crisman JM, Diamond JR, (2000) Angiotensinogen and AT (1) antisense inhibition of osteopontin translation in rat proximal tubular cells. Am J Physiol Renal Physiol 278: 708-716.
28. Noda M, Rodan GA, (1989) Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormone. J Cell Biol 108: 713-718.
29. Hullinger TG, Pan Q, Viswanathan HL, Somerman MJ, (2001) TGF beta and BMP-2 activation of the OPN promoter: roles of smad- and hox-binding elements. Exp Cell Res 262: 69-74.
30. Sodhi CP, Phadke SA, Batlle D, Sahai A, (2001) Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis: role of osteopontin. Am J Physiol Renal Physiol 280: 667-674.
31. Scatena M, Liaw L, Giachelli CM, (2007) Osteopontin: A multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 27: 2302-2309.
32. Agnholt J, Kelsen J, Schack L, Hvas CL, Dahlerup JF, et al. (2007) Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease. Scand J Immunol 65: 453-460.
33. Standal T, Borset M, Sundan A, (2004) Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp Oncol 26: 179-184.
34. Fedarko NS, Jain A, Karadag A, Van Eman MR, Fisher LW, (2001) Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res 7: 4060-4066.
35. Singhal H, Bautista DS, Tonkin KS, O'Malley FP, Tuck AB, et al. (1997) Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clin Cancer Res 3: 605-611.
36. Comabella M, Pericot I, Goertsches R, Nos C, Castillo M, (2005) et al. Plasma osteopontin levels in multiple sclerosis. J Neuroimmunol 158: 231-239.
37. Wong CK, Lit LC, Tam LS, Li EK, Lam CW, (2005) Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. Rheumatology 44: 602-606.
38. Xu L, Ma X, Wang Y, Li X, Qi Y, et al. (2011) The expression and pathophysiological role of osteopontin in Grave's disease. J Clin Endocrinol Metab 96: 1866-1870.
39. Ambrosi GJ, Catalan V, Ramirez B, Rodriguez A, Colina I, et al. (2007) Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J Clin Endocrinol Metab 92: 3719-3727.
40. Gursoy G, Alagoz S, Acar Y, Demirbas B, Centiner H, et al. (2010) Osteopontin a new probable marker for atherosclerosis in obese women. Clin rev opin 2: 35-40.
41. Fitzpatrick LA, Severson A, Edwards WD, Ingram RT, (1994) Diffuse calcification in human coronary arteries: association of osteopontin with atherosclerosis. J Clin Invest 94: 1597-1604.
42. Golledge J, McCann M, Mangan S, Lam A, Karan M, (2004) Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis. Stroke 35: 1636-1641.
43. Hirota S, Imakita M, Kohri K, Ito A, Morii E, et al. (1993) Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification. Am J Pathol 143: 1003-1008.
44. Kwon HM, Hong BK, Kang TS, Kwon K, Kim HK, et al. (2000) Expression of osteopontin in calcified coronary atherosclerotic plaques. J Korean Med Sci 15: 485-493.
45. Shanaham CM, Cary NR, Metcalfe JC, Weissberg PL, (1994) High expression of genes for calcification regulation proteins in human atherosclerotic plaques. J Clin Invest 93: 2393-2402.
46. Wada T, McKee MD, Steitz S, Giacheli CM, (1999) Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ Res 84: 166-178.
47. Kurata M, Okura T, Watanabe S, Fukuoka T, Higaki J, (2006) Osteopontin and carotid atherosclerosis in patients with essential hypertension. Clin Sci 111: 319-324.
48. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates F, et al. (1995) The incidence of thyroid disorder in the community: a twenty year follow-up of the Whickham survey. Clin Endocrinol 43: 55-68.
49. Baral N, Lamsal M, Koner BC, Koirala S, (2002) Thyroid dysfunction in eastern Nepal. Southeast Asian J Trop Med Public Health. 33: 638-641.
50. Blake CA, McCoy GL, Hui YY, LaVoie HA, (2011) Perinatal exposure to low dose DE-71 increases serum thyroid hormones and gonadal osteopontin gene expression. Exp Biol Med 236: 445-455.
51. Liou YM, Chang LY, Liaw JM, Jiang MJ, (2005) Osteopontin gene expression in the aorta and in the heart of propylthiouracil induced hypothyroid mice. J Biomed Sci 12: 869-880.
52. Briese J, Cheng S, Ezzat S, Liu W, Winer D, et al. (2010) Osteopontin (OPN) expression in thyroid carcinoma. Anticancer Res 30: 1681-1688.
53. Guarino V, Faviana P, Salvatore G, Castellone MD, Cirafici AM, et al. (2005) Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness. J Clin Endocrinol Metab 90: 5270-5278.
54. Sharp JA, Sung V, Slavin J, Thompson EW, Henderson MA, (1999) Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer. Lab Invest 79: 869-877.